Therapeutic Areas
Oncology
|
Execute continuous flow cell based assays and advanced transmigration assays superseding existing transwell migration assay
The VenaFluxTM Platform from Cellix is ideal for the study of cancer cell movement in an in-vitro experimental set up mimicking in-vivo conditions of the blood vessel. Using live cell imaging, interactions of cancer cells with proteins of the blood vessel wall can be visualised using Vena8TM biochips while cell-cell interactions can be investigated using VenaECTM biochips.
These key prerequisite steps to transmigration give researchers a greater understanding of how cancer cells move out of the human blood vessel before developing into secondary tumors. Cellix have validated their technology in the following areas: Melanoma and Breast Cancer. Both are of particular interest due to the high metastatic potential. Cellix's technology provides a key future research tool for this area.
Oncology
|
|
|
.jpg)
